Citation:
Efentakis P, Iliodromitis E, Varela A, Chavdoula E, Sigala F, Kostomitsopoulos N, Farmakis D, Tasouli A, Papapetropoulos A, Klinakis A, et al. Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action: P4229. European Heart Journal. 2017;38.